HIGHLIGHTS FROM 40th
ICAAC
(Interscience Conference on
Antimicrobial Agents and Chemotherapy)
September 17-20, 2000, Toronto, Canada
Written for NATAP by Harvey S. Bartnof, MD, Staff Physician at AVERI, AIDS Virus Education and Research Institute, San Francisco, California
More than 13,000 physicians and researchers attended the 40th ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), a conference that is considered to be the most important one worldwide in the area of infectious diseases. There were 283 abstracts (12% of total) about HIV/AIDS and 43 abstracts about hepatitis. All references listed are from the 40th ICAAC.
THE ARTICLES:
New Research Findings
HIV Clinical Studies
Experimental Treatments
for HIV
New Formulations of Existing Drugs for HIV
Anti-HIV Drug Side Effects/Hepatitis C Virus Co-Infection
with HIV
Liver Disease and Dose Changes for Anti-HIV Drugs
Experimental Treatments for Hepatitis B Virus Infection
Link to additional NATAP ICAAC Reports: